Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Balt Group is a global medical device company headquartered in Montmorency, France. Its official website serves as a group-level institutional and product showcase. The company focuses on neurovascular interventional treatment, covering ischemic stroke, hemorrhagic stroke, aneurysms, and related embolization therapies, while also expanding into peripheral vascular embolization. The site clearly states that its content does not constitute medical advice, and product availability depends on regulatory approval status in each country or region.
The official website mainly provides four types of information: first, an introduction to the group, including its mission, management team, history of innovation, and global offices; second, its product portfolio, such as microcatheters, guide catheters, stents, coils, liquid embolic agents, aspiration catheters, balloon catheters, and more; third, news and clinical updates, such as the publication of the STEM trial related to SQUID liquid embolic agents in the New England Journal of Medicine; and fourth, the Balt Prime education portal, which provides educational videos, expert exchanges, and treatment-area content for professionals.
The website does not publicly list product prices or offer online purchasing. As highly regulated medical devices, procurement is usually handled through hospital tenders, regional sales teams, distributors, or direct communication with group offices. Actual pricing may vary depending on national registration status, product model, purchase volume, clinical use case, and after-sales support.
The advantages are its strong professional focus, deep historical expertise, product lines covering multiple key areas of neurointervention, and support from global offices and clinical research. The website also shows a strong compliance awareness, with explanations regarding medical advice, regional applicability, data privacy, and cookies. The drawbacks are that the information is more presentation-oriented, lacking complete registration certificates, detailed clinical materials, product specification comparisons, and clear purchasing pathways. Chinese localization is limited, and ordinary patients may also find it difficult to obtain actionable medical guidance directly from the official website.
It is better suited for neurointerventional physicians, stroke centers, hospital procurement teams, medical device distributors, clinical researchers, and industry partners. Ordinary patients can use it to understand the company’s background, but specific treatment plans should still be discussed with a qualified doctor.
Based on the crawled content, Balt has an office in Beijing, and the website also adjusts its content framework according to geographic location. The domain itself does not appear to require login or special network conditions, so it is likely directly accessible from mainland China. However, third-party components such as Google Analytics may load inconsistently, though this should not affect browsing the main content.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on baltgroup.com official site.
baltgroup.com is an France Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of China direct-connect friendly. Click "Visit Official Site" to reach baltgroup.com directly.